CD8A and systemic lupus erythematosus: Together, these findings suggest that a composite cytotoxic signature provides superior discriminative power for distinguishing active from inactive SLE, reinforcing the relevance of CD8+ T-cell-related pathways in the pathogenesis and stratification of disease activity.